Acyclovir Entrapped N-Trimethyl Chitosan Nanoparticles for Oral Bioavailability Enhancement

Author(s): Ushasree Medikonduri, Zenab Attari, Krishnamurthy Bhat, Shaila Lewis

Journal Name: Current Nanoscience

Volume 12 , Issue 3 , 2016


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Objective: The aim of the study was to evaluate a nanoparticulate system composed of Ntrimethyl chitosan (TMC) for improving the oral bioavailability of Acyclovir (ACV).

Methods: TMC was prepared by methylation of chitosan and characterized by H-NMR spectroscopy. The ionic gelation method was used to prepare ACV loaded TMC nanoparticles. Non-everted sac technique was used to assess ex vivo permeation in rats. A pharmacokinetic study of the optimized formulation was carried out in male Wistar rats in comparison with ACV alone.

Results: Ex vivo studies exhibited a significant rise in the permeation of ACV from the rat intestinal membrane when formulated as nanoparticles. The results showed an increase in plasma concentration of ACV from the nanoformulation and significant difference (p < 0.05) in pharmacokinetic parameters as compared to pure drug, ACV.

Conclusion: The results suggest that higher oral delivery of ACV can be achieved by combining the benefits of both TMC and nanoparticles.

Keywords: Acyclovir, ionic gelation, nanoparticle, oral drug delivery, trimethyl chitosan.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 12
ISSUE: 3
Year: 2016
Published on: 04 April, 2016
Page: [378 - 385]
Pages: 8
DOI: 10.2174/1573413712666151124194414
Price: $65

Article Metrics

PDF: 30
HTML: 2
EPUB: 1
PRC: 2